Diuretic Resistance and the Efficacy of Hydrochlorothiazide in Acute Decompensated Heart Failure: A Post-Hoc Analysis of the CLOROTIC Trial
The BAN-ADHF score demonstrated good performance in identifying DR, and high DR risk was associated with worse outcomes. HCTZ treatment response on weight loss was similar across DR risk, but improvement in dyspnoea with HCTZ was attenuated in high DR risk.
Authors
- Pau Llàcer (ORCID: https://orcid.org/0000-0002-0988-0599)
- Matthew W. Segar (ORCID: https://orcid.org/0000-0001-6100-0897)
- Jesús Casado (ORCID: https://orcid.org/0000-0003-4721-0446)
- Françesc Formiga (ORCID: https://orcid.org/0000-0002-3587-298X)
- Neil Keshvani (ORCID: https://orcid.org/0000-0001-6890-8670)
- Harriette G.C. Van Spall (ORCID: https://orcid.org/0000-0002-8370-4569)
- Luís Manzano (ORCID: https://orcid.org/0000-0002-0472-1820)
- Joan Carles Trullàs
- Ambarish Pandey
- José Luís Morales‐Rull
Institutions
- Universitat de Vic - Universitat Central de Catalunya (ES)
- Houston Methodist (US)
- Universidad de Alcalá (ES)
- Bellvitge University Hospital (ES)
- Hospital Universitari Arnau de Vilanova (ES)
- Generalitat Valenciana (ES)
- Population Health Research Institute (CA)
- Southwestern Medical Center (US)
- Hospital Universitario de Getafe (ES)
- Baylor Medical Center at Garland (US)
- Heart Hospital Baylor Plano (US)
- Hospital de Manises (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Instituto de Investigación Biomédica de Lleida (ES)
- Hospital Comarcal de Inca (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Southwestern Medical Center (US)
- Hamilton Health Sciences (CA)
- The University of Texas Southwestern Medical Center (US)
- McMaster University (CA)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1002/ejhf.70002
- Citations
- 4
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.55